These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 16377646

  • 1. Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal of neuromuscular block in anaesthetized Rhesus monkeys.
    de Boer HD, van Egmond J, van de Pol F, Bom A, Booij LH.
    Br J Anaesth; 2006 Feb; 96(2):201-6. PubMed ID: 16377646
    [Abstract] [Full Text] [Related]

  • 2. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.
    de Boer HD, van Egmond J, van de Pol F, Bom A, Booij LH.
    Br J Anaesth; 2006 Apr; 96(4):473-9. PubMed ID: 16464982
    [Abstract] [Full Text] [Related]

  • 3. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation.
    de Boer HD, van Egmond J, van de Pol F, Bom A, Driessen JJ, Booij LH.
    Br J Anaesth; 2006 Nov; 97(5):681-6. PubMed ID: 17018564
    [Abstract] [Full Text] [Related]

  • 4. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK, Caldwell JE, Brull SJ, Soto RG.
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [Abstract] [Full Text] [Related]

  • 5. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA, Mastronardi P, Hunter JM, Gomar C, Mirakhur RK, Aguilera L, Giunta FG, Meistelman C, Prins ME.
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [Abstract] [Full Text] [Related]

  • 6. Reversal of profound rocuronium neuromuscular blockade by sugammadex in anesthetized rhesus monkeys.
    de Boer HD, van Egmond J, van de Pol F, Bom A, Booij LH.
    Anesthesiology; 2006 Apr; 104(4):718-23. PubMed ID: 16571967
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.
    Abdulatif M, Mowafi H, al-Ghamdi A, el-Sanabary M.
    Br J Anaesth; 1996 Dec; 77(6):710-5. PubMed ID: 9014620
    [Abstract] [Full Text] [Related]

  • 10. Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969.
    Epemolu O, Bom A, Hope F, Mason R.
    Anesthesiology; 2003 Sep; 99(3):632-7; discussion 6A. PubMed ID: 12960547
    [Abstract] [Full Text] [Related]

  • 11. Spontaneous or neostigmine-induced recovery after maintenance of neuromuscular block with Org 9487 (rapacuronium) or rocuronium following an initial dose of Org 9487.
    McCourt KC, Mirakhur RK, Lowry DW, Carroll MT, Sparr HJ.
    Br J Anaesth; 1999 May; 82(5):755-6. PubMed ID: 10536556
    [Abstract] [Full Text] [Related]

  • 12. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block.
    Shields M, Giovannelli M, Mirakhur RK, Moppett I, Adams J, Hermens Y.
    Br J Anaesth; 2006 Jan; 96(1):36-43. PubMed ID: 16357116
    [Abstract] [Full Text] [Related]

  • 13. Neuromuscular and cardiovascular effects of neostigmine and methyl-atropine administered at different degrees of rocuronium-induced neuromuscular block.
    Van den Broek L, Proost JH, Wierda JM, Njoo MD, Hennis PJ.
    Eur J Anaesthesiol; 1994 Nov; 11(6):481-7. PubMed ID: 7851356
    [Abstract] [Full Text] [Related]

  • 14. [Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial].
    Barrio J, San Miguel G, García V, Pelegrín F.
    Rev Esp Anestesiol Reanim; 2007 Nov; 54(7):399-404. PubMed ID: 17953333
    [Abstract] [Full Text] [Related]

  • 15. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A, Ho J, Wong J, Yin L, Chung F.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD007362. PubMed ID: 19821409
    [Abstract] [Full Text] [Related]

  • 16. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide.
    Gijsenbergh F, Ramael S, Houwing N, van Iersel T.
    Anesthesiology; 2005 Oct 07; 103(4):695-703. PubMed ID: 16192761
    [Abstract] [Full Text] [Related]

  • 17. Sugammadex reversal of rocuronium-induced neuromuscular block in Caesarean section patients: a series of seven cases.
    Pühringer FK, Kristen P, Rex C.
    Br J Anaesth; 2010 Nov 07; 105(5):657-60. PubMed ID: 20736231
    [Abstract] [Full Text] [Related]

  • 18. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†,
    Kaufhold N, Schaller SJ, Stäuble CG, Baumüller E, Ulm K, Blobner M, Fink H.
    Br J Anaesth; 2016 Feb 07; 116(2):233-40. PubMed ID: 26787792
    [Abstract] [Full Text] [Related]

  • 19. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y, Ochiai R, Suzuki T, Ogawa S, Takagi S, Ozaki M, Nakatsuka I, Takeda J.
    Anesth Analg; 2013 Aug 07; 117(2):345-51. PubMed ID: 23757472
    [Abstract] [Full Text] [Related]

  • 20. Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium.
    Choi ES, Oh AY, Seo KS, Hwang JW, Ryu JH, Koo BW, Kim BG.
    Anaesthesia; 2016 Apr 07; 71(4):443-9. PubMed ID: 26874258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.